Volume 62, Issue 1 pp. 101-109
Original Articles: Hepatology

Effectiveness of Enteral Versus Oral Nutrition With a Medium-Chain Triglyceride Formula to Prevent Malnutrition and Growth Impairment in Infants With Biliary Atresia

Rocío Macías-Rosales

Rocío Macías-Rosales

Servicio Gastroenterología y Nutrición, Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco

Search for more papers by this author
Alfredo Larrosa-Haro

Corresponding Author

Alfredo Larrosa-Haro

Instituto de Nutrición Humana, Centro Universitario de Ciencias de la Salud, Departamento de Clínicas de la Reproducción Humana Crecimiento y Desarrollo Infantil, Universidad de Guadalajara, Guadalajara, Jalisco

Address correspondence and reprint requests to Alfredo Larrosa-Haro, MD, PhD, Instituto de Nutrición Humana, Departamento de Clínicas de la Reproducción Humana, Crecimiento y Desarrollo Infantil, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Salvador Quevedo y Zubieta 750, Sector Libertad, Guadalajara, Jalisco, México, CP 43240 (e-mail: [email protected]).Search for more papers by this author
Genaro Ortíz-Gabriel

Genaro Ortíz-Gabriel

Centro de Investigación Biomédica de Occidente, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco

Search for more papers by this author
Benjamín Trujillo-Hernández

Benjamín Trujillo-Hernández

Unidad de Investigación y Epidemiología Clínica, Hospital General de Zona No. 1, Colima, México

Search for more papers by this author
First published: 01 January 2016
Citations: 26

The authors report no conflicts of interest.

ABSTRACT

Objectives:

The aim of this study was to compare the effectiveness of oral (PO) versus enteral nutrition (EN) medium-chain triglyceride (MCT) containing–formula to prevent malnutrition and growth impairment in infants with biliary atresia (BA) waiting for a liver transplant.

Methods:

A total of 15 infants, 3 to 9 months old with BA were included. They were randomly assigned to either PO or EN. For 12 weeks, both groups received an MCT formula fortified with glucose polymers and corn oil to reach a caloric density between 0.8 and 1 kcal/mL. The formula given to the PO group was administered ad libitum and that given via EN was infused through a nasogastric tube to reach 140% of the energy intake recommended by the Dietary Recommended Intake guidelines. Protein intake was adjusted to 4 to 5 g/kg present weight. Outcome variables were growth and nutritional status evaluated periodically by anthropometric indicators. Biochemical and hematological variables were evaluated through the study.

Results:

Baseline clinical, nutritional, biochemical, and hematological variables showed no differences between the study groups. Baseline length/age was <−2 SD in 10 of the 15 patients; in the PO group, it fell <−3 SD, whereas in the EN group, it remained stable. Head circumference z score dropped 0.6 SD in the PO group, whereas in the EN group it remained stable. Triceps skinfold values improved in the infants taking EN, P < 0.001. The frequency of adverse effects—respiratory infection and diarrhea—was higher in the EN group. No biochemical or hematological differences were observed between the study groups throughout the study.

Conclusions:

A 12-week EN trial with an MCT-fortified formula prevented malnutrition and growth impairment in infants with BA waiting for a liver transplant.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.